Frazier Lifesciences Acqu... (FLACU)

NASDAQ: FLACU · Real-Time Price · USD

9.50

0.23 (2.48%)

At close: Nov 22, 2022, 8:59 PM

Frazier Lifesciences Acquisition Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Net Income	-4.78M	-1.17M	1.38M	929.7K	1.73M	-1.3M	2.82M	-126.81K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	3.65M	1M	65.68K	-76.58K	234.96K	28.98K	35.7K	-474.64K
Other Non-Cash Items	n/a	n/a	-1.73M	-384.28K	-2.1M	994.05K	-3.06M	42.35K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	4.54M	1M	-49.06K	45.7K	215.32K	-67.9K	34.78K	-415.54K
Operating Cash Flow	-239.9K	-172.6K	-393.68K	591.13K	-153.91K	-373.14K	-202.46K	-500K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-138M
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-138M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	-45K	n/a	n/a	n/a	n/a	139.87M
Financial Cash Flow	n/a	n/a	-45K	n/a	n/a	n/a	n/a	139.87M
Net Cash Flow	-239.9K	-172.6K	-438.68K	591.13K	-153.91K	-373.14K	-202.46K	139.87M
Free Cash Flow	-239.9K	-172.6K	-393.68K	591.13K	-153.91K	-373.14K	-202.46K	-500K